Nebraska Medicine Fred and Pamela Buffett Cancer Center — Omaha, Nebraska

Nebraska Medicine Fred and Pamela Buffett Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68105.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Medicine Fred and Pamela Buffett Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Lymphoma Non-Hodgkin, Agressive Lymphoma, Diffuse-large B-cell Lymphoma (DLBCL).

Sponsors: Juno Therapeutics, a Subsidiary of Celgene.

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Medicine Fred and Pamela Buffett Cancer Center?

Nebraska Medicine Fred and Pamela Buffett Cancer Center has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Medicine Fred and Pamela Buffett Cancer Center conducted?

Nebraska Medicine Fred and Pamela Buffett Cancer Center has 1 clinical trials on record. Their work covers Lymphoma Non-Hodgkin, Agressive Lymphoma, Diffuse-large B-cell Lymphoma (DLBCL).

Is Nebraska Medicine Fred and Pamela Buffett Cancer Center accredited by Crixeo Health?

Nebraska Medicine Fred and Pamela Buffett Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Medicine Fred and Pamela Buffett Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.